- Inicio
- Análisis de app
- CRUSE Control Urticaria
- CRUSE Control Urticaria Vs. EADV Congress 2024
CRUSE Control Urticaria vs EADV Congress 2024 Uso & Estadísticas
CRUSE® is an APP developed by renowned dermatologists and allergoligists to help patients with Chronic Urticaria manage their condition.
Take control of your Chronic Urticaria by recording your symptoms and impact on your quality of life in just a few minutes each day.
Track how you respond to treatment and how it can be improved by using CRUSE in cooperation with your treating physician.
Over 50 million people worldwide have Chronic Urticaria. It is a common condition that causes itchy wheals and/or swellings (angioedema) and can be very debilitating. To ensure optimal treatment, continuous monitoring and documentation of disease activity is essential. From now on, CRUSE® will take care of this for you.
Your UCARE Team - With more than 130 member centres in 41 countries, GA²LEN’s Urticaria Centres of Reference and Excellence (UCARE network) is the biggest and most active consortium of urticariologists and urticaria centres.
Are you a physician? Find out more on www.cruse-control-com
- App Store de Apple
- Gratis
- Medicina
Clasificación de tiendas
- -
The EADV Congress app allows access to the content of the Congress, ask questions during the sessions, and access your CME evaluations.
- App Store de Apple
- Gratis
- Medicina
Clasificación de tiendas
- -
CRUSE Control Urticaria frente a EADV Congress 2024: comparación de la clasificación
Comparar la tendencia de clasificación de CRUSE Control Urticaria en los últimos 28 días con EADV Congress 2024
Rank
No hay datos disponibles
Comparación de las clasificaciones CRUSE Control Urticaria frente a EADV Congress 2024 por países
Comparar la tendencia de clasificación de CRUSE Control Urticaria en los últimos 28 días con EADV Congress 2024
Todas las categorías
No hay datos disponibles
Medicina
Compara con cualquier sitio gracias a nuestra prueba gratuita
CRUSE Control Urticaria VS.
EADV Congress 2024
10iciembre d, 2024